Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

By sjmartinez • September 2, 2022

Gong J, Thomassian S, Kim S, Gresham G, Moshayedi N, Ye JY, Yang JC, Jacobs JP, Lo S, Nissen N, Gaddam S, Tighiouart M, Osipov A, Hendifar A. Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Sci Rep. 2022 Sep 2;12(1):15013. doi: 10.1038/s41598-022-19401-3. PMID: 36056179; PMCID: PMC9440135.

Tags: Digestive Diseases, General Internal Medicine, Publications

Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study

Asiimwe E, May F, Bendavid E. Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study.[...]

New Basic Science Editor and New Journal Management Committee Chair of Neurogastroenterology and Motility!

Corsetti M, Zerbib F, Black C, Shin A, Browning K, Keszthelyi D, Jones M. New Basic Science Editor and New Journal Management Committee Chair of[...]

Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta-Analysis

Maniyar I, Jajoo A, Brewer GG, Iyengar P, Nguyen A, Fasulo C, White J, Parian A, Limketkai BN. Dietary Sugar and Sweetened Beverage Intake Increases[...]